Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Radiation Oncology
•
Genitourinary Cancers
For patients with metastatic RCC and gross hematuria from the primary tumor, what palliative radiation regimen would you recommend to help control the bleeding?
In this example, the patient is unresponsive to primary therapy with on-goin hematuria.
Related Questions
Given the different rates of testosterone recovery, do you alter the duration of ADT when using Leuprorelin (GnRH Agonist) vs relugolix (GnRH antagonist) in patients with intermediate or high-risk prostate cancer who received definitive radiation?
What is your experience with Pylarify vs. Posluma PSMA PET for prostate cancer and is one preferred over the other?
How do you approach Lu-177 use in taxane-naive patients with metastatic prostate cancer?
Would you use fezolinetant for hot flashes for men on ADT?
Do you recommend radiation in a patient with BAP1Tumor Predisposition Syndrome with prior RCC with recurrent brain met after previous resection?
In patients who have residual bladder tumors after maximal TURBT, would you boost the GTV above typical doses, 55 Gy/20 fractions or 64 Gy/32 fractions, assuming you can meet constraint?
Are there any contraindications to Pluvicto therapy you personally use, given that there are none directly provided by the manufacturer?
How would you approach de novo metastatic castrate sensitive prostate cancer with extensive locoregional spread causing rectal compression, retroperitoneal lymphadenopathy, and PSA >3000 but no visceral or bone metastases?
Is there any evidence for amyloid/amyloidosis causing a spurious/false PSA reading?
Do you need renal biopsy before SBRT for RCC suspicious cancer?